Show simple item record

MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms

dc.contributor.authorHancer, Veysel Sabri
dc.contributor.authorNalcaci, Meliha
dc.contributor.authorAkpinar, Timur Selcuk
dc.contributor.authorDiz-Kucukkaya, Reyhan
dc.date.accessioned2021-03-05T21:51:36Z
dc.date.available2021-03-05T21:51:36Z
dc.date.issued2013
dc.identifier.citationAkpinar T. S. , Hancer V. S. , Nalcaci M., Diz-Kucukkaya R., "MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms", TURKISH JOURNAL OF HEMATOLOGY, cilt.30, ss.8-12, 2013
dc.identifier.issn1300-7777
dc.identifier.othervv_1032021
dc.identifier.otherav_daed27cd-898f-41ca-8103-4357fc512783
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144295
dc.identifier.urihttps://doi.org/10.4274/tjh.65807
dc.description.abstractObjective: The MPL gene encodes the thrombopoietin receptor. Recently MPL mutations (MPL W515L or MPL W515K) were described in patients with essential thrombocythemia (ET) and primary (idiopathic) myelofibrosis (PMF). The prevalence and the clinical importance of these mutations are not clear. In the present study, we aimed to investigate the frequency and clinical significance of MPL W515L/K mutations in our patients with ET and PMF.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectHEMATOLOJİ
dc.titleMPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume30
dc.identifier.issue1
dc.identifier.startpage8
dc.identifier.endpage12
dc.contributor.firstauthorID208461


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record